Abstract
To determine efficacy and safety of OnabotulinumtoxinA (BoNT-A) injection therapy in medically refractory patients with lower urinary tract symptoms (LUTS) due to primary bladder-neck dysfunction (PBND).
| Original language | English |
|---|---|
| Pages (from-to) | 142-146 |
| Number of pages | 5 |
| Journal | Neurourology and Urodynamics |
| Volume | 33 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2014 |
All Science Journal Classification (ASJC) codes
- Clinical Neurology
- Urology
Keywords
- lower urinary tract symptoms
- onabotulinumtoxina
- primary bladder-neck dysfunction
- urinary bladder-neck obstruction
Fingerprint
Dive into the research topics of 'OnabotulinumtoxinA injection therapy in men with LUTS due to primary bladder-neck dysfunction: objective and patient-reported outcomes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver